National Diabetes Audit
Audit collects Information about general diabetes care. Data submitted by health care services, relevant to service they provide i.e. Secondary Care Bodies = Type 1, GP practices = Type 2. Includes demographics and diabetes relevant biometric information. The National Diabetes Audit (NDA) is part of the National Clinical Audit and Patient Outcomes Programme, which is managed by the Healthcare Quality Improvement Partnership (HQIP) and funded by NHS England. The Core NDA collects information for a 15-month audit period. This is collected from both primary and secondary care services – for example: • 2019-20 audit collects for the period 1 January 2019 to 31 March 2020 • 2020-21 audit collects for the period 1 January 2020 to 31 March 2021 Annual data is typically released in November. Quarterly data collection The data is extracted quarterly from general practices via the General Practice Extraction Service (GPES). Indicative timings for extraction are: • August 2019: collection of data from January to June 2019 • November 2019: collection of data from January to September 2019 • February 2020: collection of data from January to December 2019 • May 2020: collection of full audit year data The first 3 quarters of data are typically published the month after extraction. The NDA started in 2003-4 as part of the Diabetes National Service Framework (NSF) implementation plan to provide reliable measurements for service improvement and monitor the impact of the NSF. The core components of the NDA were designed to align with the Diabetes NSF, The National Institute for Health and Care Excellence (NICE) guidelines and Quality Standards in respect of achievement rates for annual care process, and treatment targets and disease measure including premature mortality. It integrates data reflecting contributions from all primary and secondary care providers and captures data on over 3 million people with diabetes each year. Since 2010 new elements have been incorporated into the audit programme to include specialised care pathways. The NDA programme now reports on: • Care processes and Treatment Targets (NDA Core) • Complications and Mortality (NDA Core) • Pregnancy in women with diabetes (NPID) • Foot ulcer management in people with diabetes (NDFA) • Continuous Subcutaneous Insulin Infusion in people with Type 1 Diabetes • Care of in-patients with diabetes (NaDIA) • Complications related to the four main harms that can occur to inpatients with diabetes in Acute hospitals in England (NaDIA – Harms) • Transitional care for people with diabetes through childhood to adulthood • Progress on invitation to attend and uptake of offer in the NHS Diabetes Prevention Programme The inclusion of NDA in the GP Contract allowed collection of data directly from primary care systems via the GPES for NDA Core primary care data. This has resulted in increased participation and reduction in burden on primary care providers due to the automated nature of GPES. Participation from both primary care and secondary care has increased year on year, now at its highest level since NDA commenced in 2003. https://digital.nhs.uk/data-and-information/clinical-audits-and-registries/national-diabetes-audit
Webpage:
https://www.healthdatagateway.org/dataset/c2e112a0-a198-46b0-9a0c-ec91edfb6839
Licence:
Name: HDR UK Innovation Gateway Access
Tags:
diabetes type 2 insulin type 1 digitrials
Need help integrating and/or managing biomedical data?